MedPath

Study of herbal drug of HESA-A on dry Age related Macular Degeneratio

Phase 2
Conditions
Dry age related macular degeneration.
Senile Macular Degeneration( Atrophic)
Registration Number
IRCT2013091514667N1
Lead Sponsor
Hamedan university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion criteria are mild or moderate loss of vision due to AMD including: non-central atrophy, RPE changes, multiple intermediate drusens (64-124 microns) or one large drusen ( diameter more than 124 microns) at least in one eye. Exclusion criteria are Corrected visual acuity less than 20/200, CNV or presence of any other ocular disease except mild cataract (1+)

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Corrected visual acuity. Timepoint: before intervention and every month. Method of measurement: snellen chart.
Secondary Outcome Measures
NameTimeMethod
Choroidal neovascularization. Timepoint: before intervention and every month. Method of measurement: fluorescein angiography and OCT of retina.;Ophthalmic or systemic side effects. Timepoint: every month in follow up period. Method of measurement: examination with slit lamp, super field lens and goldman tonometer.
© Copyright 2025. All Rights Reserved by MedPath